Obesity Statistics in Australia 2026 | Rates, GLP-1 Access & Facts

Obesity in Australia 2026

Obesity in Australia has now overtaken tobacco as the country’s single biggest driver of preventable illness, and the latest 2026 government data confirms the crisis is still deepening rather than levelling off. According to the Australian Institute of Health and Welfare (AIHW), around 67% of Australian adults aged 18 and over — roughly 13.2 million people — were living with overweight or obesity in 2022–24, including 33% classified as obese outright. Among children and adolescents aged 2 to 17, 27% — about 1.4 million young Australians — were living with overweight or obesity, with 8.5% already in the obesity range. These aren’t small shifts on the margins; obesity alone became the leading risk factor for death and illness in the country in 2024, overtaking smoking for the first time in Australia’s recorded health history.

This report brings together the newest verified statistics on Australia’s obesity crisis in 2026, sourced exclusively from the AIHW, the Australian Bureau of Statistics (ABS), and the Pharmaceutical Benefits Scheme (PBS). It covers adult and childhood prevalence, how rates break down by sex, age, and geography, the disproportionate burden carried by Aboriginal and Torres Strait Islander communities, the ballooning healthcare and economic cost of the epidemic, and — critically — the current state of GLP-1 medication access in Australia, including why drugs like Wegovy and Ozempic remain largely unsubsidised for weight loss as of mid-2026. Every figure below is drawn from official government sources and cross-checked for accuracy against the most recently published releases.

Interesting Facts: Obesity Statistics in Australia 2026

Source: Australian Institute of Health and Welfare, Overweight and Obesity report, 2026.

Australia’s obesity numbers in 2026 paint a picture of a health system under sustained strain from a single, largely preventable condition. The jump from 19% adult obesity in 1995 to 33% today shows this isn’t a recent spike but a three-decade climb that has now reached a point where two in every three adults carry excess weight. What makes the 2024 disease burden finding especially significant is that overweight and obesity displaced tobacco as Australia’s top contributor to ill health and premature death — a symbolic and practical turning point, since tobacco control was long considered the country’s public health success story. The $10.8 billion in annual health spending tied to the condition, combined with 19,000 associated deaths in a single year, underlines that this is now as much an economic and workforce issue as a clinical one.

Equally striking is the gap between adult and child prevalence trends. While 27% of children and adolescents live with overweight or obesity — a figure that has crept up from 20% in 1995 — the adult obesity rate has grown far faster, suggesting that weight gain increasingly accumulates through adulthood rather than being set in childhood alone. The abdominal obesity data, where 48% of all adults and more than half of all women exceed healthy waist-circumference thresholds, adds an extra layer of concern because abdominal fat carries an independently higher risk for type 2 diabetes, heart disease, and metabolic syndrome than BMI alone captures. Together, these figures explain why overweight and obesity now sit at the centre of Australia’s national chronic-disease prevention strategy heading into 2026.

Adult Obesity Rates in Australia 2026

ADULT OVERWEIGHT & OBESITY IN AUSTRALIA — 2022-24 NHMS DATA
════════════════════════════════════════════════════════════
  Overweight or obese (all adults)   ███████████████████████  67%
  Obese specifically                 ████████████████         33%
  Overweight only (not obese)        ████████████████████     34%
  Male: overweight or obese          ████████████████████████ 72%
  Female: overweight or obese        █████████████████████    62%
════════════════════════════════════════════════════════════

Source: Australian Institute of Health and Welfare, analysis of ABS National Health Measures Survey 2022–24.

The core national figure — 67% of Australian adults living with overweight or obesity — has held broadly steady since 2017–18, but that stability masks a significant internal shift: the obesity share specifically rose from 31% to 33% over the same window, meaning more people are moving from the overweight category into the more serious obesity category even while the combined total plateaus. This matters because obesity carries substantially higher clinical risk than simple overweight, particularly for cardiovascular disease, type 2 diabetes, and certain cancers, so a stable headline number can still represent a worsening underlying health picture.

The sex gap in these figures is also worth unpacking. 72% of Australian men compared with 62% of women live with overweight or obesity, and the AIHW attributes most of that difference to men’s substantially higher rate of overweight specifically — 38% versus 30% — rather than obesity, where the two sexes are closer together. This pattern is broadly consistent with obesity trends recorded across other high-income nations, and readers comparing international patterns may find it useful to look at the equivalent Canada obesity statistics, where a similar male-skewed overweight gap has been recorded in the most recent national health survey.

Childhood and Adolescent Obesity in Australia 2026

CHILDREN & ADOLESCENTS (AGES 2-17) — OVERWEIGHT/OBESITY 2026
════════════════════════════════════════════════════════════
  Overweight or obese (all, 2–17)    █████████████            27%
  Obese specifically                 ████████                 8.5%
  Lowest SES areas                   ██████████████████       36%
  Highest SES areas                  ██████████                22%
════════════════════════════════════════════════════════════

Source: Australian Institute of Health and Welfare, Overweight and Obesity report, 2026; ABS National Health Measures Survey.

Childhood obesity in Australia has followed a slower but still-upward trajectory compared with adults, rising from 20% in 1995 to 28% by 2022–24 among the 5–17 age bracket. Unlike the adult data, where obesity specifically is climbing fastest, the childhood increase has been driven mainly by rising rates of overweight rather than obesity outright, though the 8.5% obesity rate among all 2–17 year olds remains a serious clinical concern given how strongly childhood obesity predicts adult obesity later in life.

The socioeconomic gap is the standout feature of the childhood data. Children in the lowest socioeconomic areas are overweight or obese at 36%, compared with 22% in the wealthiest areas — a 14 percentage point gap that mirrors, and in some respects exceeds, the equivalent divide seen in adults. The National Obesity Strategy 2022–2032 specifically targets a 5% reduction in childhood overweight and obesity by 2030, but current AIHW monitoring shows the national rate has not changed significantly between 2017–18 and 2022–24, meaning progress against that target remains uncertain heading into the second half of the decade.

Abdominal Obesity and Waist Circumference in Australia 2026

ABDOMINAL OBESITY (WAIST CIRCUMFERENCE) — AUSTRALIA 2022-24
════════════════════════════════════════════════════════════
  All adults                         ████████████████████    48%
  Females                            ██████████████████████  54%
  Males                              ████████████████        42%
  Abdominal ob. in 1995              ██████████              25%
  Abdominal ob. in 2022–24           ████████████████████    48%
════════════════════════════════════════════════════════════

Source: Australian Institute of Health and Welfare, analysis of ABS National Health Measures Survey 2022–24.

Waist circumference data, which measures abdominal fat distribution rather than overall body mass, tells an even more dramatic story than BMI-based figures. Abdominal obesity in Australian adults has almost doubled, from 25% in 1995 to 48% in 2022–24, meaning nearly one in every two adults now carries a waist measurement associated with substantially elevated risk of metabolic complications, independent of their overall BMI classification. The rise from 63% to 69% in combined abdominal overweight-or-obesity between 2017–18 and 2022–24 alone shows this trend has continued to accelerate even in the most recent five-year window.

The sex split here reverses the pattern seen in BMI data: while men have higher rates of overweight and obesity overall, women have significantly higher rates of abdominal obesity — 54% compared with 42% for men. This is a clinically important distinction because abdominal (visceral) fat is more strongly linked to insulin resistance, cardiovascular disease, and metabolic syndrome than fat stored elsewhere on the body, meaning population health strategies focused purely on BMI may understate the true metabolic risk carried by Australian women specifically.

Obesity by Age and Birth Cohort in Australia 2026

BIRTH COHORT COMPARISON — ABDOMINAL OBESITY AT SAME AGE
════════════════════════════════════════════════════════════
  Ages 45-54, in 2011-12             ███████████████████      46%
  Ages 45-54, in 2022-24             █████████████████████████ 55%
  Ages 25-34, in 2011-12             █████████████             27%
  Ages 25-34, in 2022-24             ██████████████████        36%
════════════════════════════════════════════════════════════

Source: Australian Institute of Health and Welfare, Birth Cohort Analysis, Overweight and Obesity report, 2026.

The AIHW’s birth cohort analysis offers one of the more revealing findings in the 2026 dataset: Australians are becoming obese younger and at higher rates than earlier generations did at the same life stage. Adults aged 25 to 34 in 2022–24 show a 36% abdominal obesity rate, compared with just 27% for people the same age surveyed in 2011–12 — a 9 percentage point jump in a single decade for an identical age bracket. The same near-decade increase shows up in the 45–54 age group, confirming this isn’t isolated to young adults alone.

By simple age, obesity and overweight prevalence rises steadily through the lifespan before peaking and then tapering slightly among the very old. Men peak at ages 65–74, where 81.4% live with overweight or obesity, while women peak slightly earlier, at ages 55–64 (69.5%). What concerns health researchers most about the birth-cohort data specifically is that each successive generation appears to be arriving at these older, higher-risk age brackets with a heavier starting point than the generation before it — a compounding trend that suggests the obesity burden on Australia’s health system will likely keep climbing even if annual prevalence growth slows.

Aboriginal and Torres Strait Islander Obesity Statistics in Australia 2026

FIRST NATIONS vs NATIONAL OBESITY RATES — AUSTRALIA 2022-23
════════════════════════════════════════════════════════════
  ATSI adults — overweight/obese       ████████████████████████ 72%
  National adults — overweight/obese   █████████████████████    67%
  ATSI children — overweight/obese     ███████████████          30%
  National children — overweight/obese █████████                27%
════════════════════════════════════════════════════════════

Source: Australian Institute of Health and Welfare, analysis of ABS National Aboriginal and Torres Strait Islander Health Survey 2022–23.

Aboriginal and Torres Strait Islander Australians carry a consistently higher obesity burden than the national average across every measure the AIHW tracks. 72% of First Nations adults live with overweight or obesity, and 44% are classified as obese — roughly 11 percentage points higher than the national obesity rate. The gap widens further for abdominal obesity, where 58% of First Nations adults exceed the risk threshold compared with 48% nationally, and it extends into childhood too, with First Nations children and adolescents showing both higher overweight/obesity (30% vs 27%) and higher obesity specifically (10% vs 8.5%) than their peers nationally.

Geography compounds this disparity in a somewhat counterintuitive direction: First Nations adults in non-remote areas actually show a higher overweight/obesity rate (73%) than those in remote areas (63%), a pattern the AIHW links to differences in food access, employment, and lifestyle between urban and remote First Nations communities. These figures sit at the centre of the National Preventive Health Strategy’s equity priorities, and the persistent gap across every age group and geography underscores why targeted, community-led health interventions — rather than one-size-fits-all national campaigns — remain central to Australia’s obesity policy response for First Nations peoples specifically.

Health Impact and Economic Cost of Obesity in Australia 2026

HEALTH & ECONOMIC IMPACT OF OBESITY — AUSTRALIA 2023-24 / 2024
════════════════════════════════════════════════════════════
  Total health spend, overweight/obesity    ████████████████ $10.8B
  Direct obesity treatment spend            ██                $0.8B
  Total deaths involving obesity (2024)     ██                2,200
  Hospitalisations, obesity principal dx    ███████████████  27,600
════════════════════════════════════════════════════════════

Source: Australian Institute of Health and Welfare, Overweight and Obesity report, 2026; AIHW Health System Spending on Disease and Injury, 2023–24.

The financial scale of Australia’s obesity epidemic is now large enough to represent a meaningful share of total national health expenditure. Of the $10.8 billion in health spending tied to overweight and obesity in 2023–24, the bulk — over $10 billion — goes toward treating downstream conditions like type 2 diabetes, chronic kidney disease, coronary heart disease, and osteoarthritis that obesity contributes to, while direct treatment of obesity itself accounts for a comparatively small $800 million. Interestingly, spending on direct obesity treatment skews heavily toward women ($570 million vs $210 million for men), even though men have higher overall obesity-linked disease spending, suggesting men and women engage differently with weight-management healthcare services.

On the mortality side, the 2024 figures show that obesity was involved in around 2,200 deaths, split between roughly 400 where it was the underlying cause and 1,800 where it was a contributing factor. The 541,000 hospitalisations where obesity was recorded as a factor affecting patient care — nearly 20 times the number where it was the principal diagnosis — illustrates how obesity acts less as a standalone hospital admission reason and more as a background condition that complicates the treatment of almost everything else, from surgery recovery to infection risk, across the Australian hospital system.

GLP-1 Weight-Loss Medication Access in Australia 2026

GLP-1 MEDICATION ACCESS IN AUSTRALIA — 2026 STATUS
════════════════════════════════════════════════════════════
  Wegovy — PBS listed for obesity?           NO (private only)
  Wegovy — PBAC positive rec (CVD+obesity)   YES (Nov 2025)
  Ozempic — PBS listed?                      YES, diabetes ONLY
  Mounjaro/Zepbound — PBS listed?            NO (TGA approved only)
  Estimated eligible adult pool (BMI 30+)    ~66% of adults
════════════════════════════════════════════════════════════

Source: Pharmaceutical Benefits Scheme (PBS), PBAC Advice on Equitable Access to GLP-1 Obesity Treatments, 2025–2026.

GLP-1 access remains the single biggest barrier standing between Australia’s 67% overweight-or-obese adult population and effective pharmacological treatment. As of 2026, Ozempic is PBS-subsidised strictly for type 2 diabetes management, meaning the millions of Australians seeking it purely for weight loss must pay full private cost. Wegovy, the higher-dose semaglutide formulation specifically indicated for obesity, is not yet listed on the PBS at all — though in November 2025 the Pharmaceutical Benefits Advisory Committee (PBAC) delivered a landmark positive recommendation to list it for patients with obesity and established cardiovascular disease, contingent on the manufacturer agreeing to a price reduction and risk-sharing arrangement. This was described by clinicians as the first-ever positive PBAC recommendation for an obesity therapy in Australia’s history, though actual listing is not expected before late 2026 at the earliest, and eligibility criteria are expected to remain narrow.

For most Australians, this means GLP-1 medications remain a private-pay proposition, with Wegovy costing roughly $395 a month and Mounjaro ranging from $280 to $750 monthly depending on dose — costs that price out a large share of the population that would clinically qualify under the standard BMI 30+ (or BMI 27+ with comorbidities) prescribing threshold. Given that the AIHW estimates roughly 66% of Australian adults fall into the overweight-or-obese category, the potential patient pool for these medicines is enormous, but affordability and the narrow scope of the pending PBS listing mean equitable access is likely to remain a contested policy question well beyond 2026. For a broader look at how these same medications are performing commercially and clinically overseas, see the latest Ozempic vs Mounjaro statistics, which breaks down market share, pricing, and efficacy data from international drug trials.

Geographic and Socioeconomic Obesity Patterns in Australia 2026

OBESITY BY GEOGRAPHY & SOCIOECONOMIC STATUS — AUSTRALIA 2022-24
════════════════════════════════════════════════════════════
  Major cities                       █████████████████████     65%
  Inner regional                     ████████████████████████  73%
  Outer regional/remote              █████████████████████████ 74%
  Lowest SES areas                   ████████████████████████  70%
  Highest SES areas                  █████████████████████     62%
════════════════════════════════════════════════════════════

Source: Australian Institute of Health and Welfare, analysis of ABS National Health Measures Survey 2022–24.

Geography is one of the strongest predictors of obesity risk once age is accounted for. Australians living in outer regional and remote areas show a 74% overweight-or-obesity rate, nine full percentage points above the 65% recorded in major cities. The AIHW attributes this gap to a combination of structural factors: reduced access to fresh, affordable food, fewer accessible recreational and fitness facilities, greater reliance on cars over active transport, and generally higher rates of socioeconomic disadvantage in regional and remote communities compared with metropolitan centres.

The socioeconomic gradient tells a similarly consistent story, with adults in the most disadvantaged areas showing a 70% overweight-or-obesity rate against 62% in the wealthiest areas — an 8 percentage point gap that widens even further for children, where the gap reaches 14 points (36% vs 22%). These overlapping geographic and socioeconomic patterns mean that Australia’s obesity burden is not evenly distributed across the population but concentrated in communities already facing the greatest barriers to healthcare access — a dynamic that mirrors patterns seen in other preventable public-health challenges tracked across the country, including the latest syphilis statistics in Australia, where remote and disadvantaged communities similarly carry a disproportionate share of national disease burden.

National Strategy and Targets for Obesity in Australia 2026

NATIONAL OBESITY TARGETS — PROGRESS CHECK 2026
════════════════════════════════════════════════════════════
  Adult obesity, 2017-18             ████████████████         31%
  Adult obesity, 2022-24             █████████████████        33%
  Target: halt & reverse by 2030     (currently trending UP)
  Child overweight/obesity, 2017-18  ████████████             25%
  Child overweight/obesity, 2022-24  █████████████            27%
  Target: -5% by 2030                (currently stable, no reduction)
════════════════════════════════════════════════════════════

Source: Australian Institute of Health and Welfare, National Strategies for Addressing Overweight and Obesity, 2026.

Australia currently operates under two overlapping national frameworks — the National Obesity Strategy 2022–2032 and the National Preventive Health Strategy 2021–2030 — which share two headline targets: halting and reversing adult obesity by 2030, and cutting childhood overweight/obesity by at least 5% over the same period. The 2026 progress check from the AIHW shows adult obesity has instead increased significantly, from 31% in 2017–18 to 33% in 2022–24, meaning Australia is currently moving in the opposite direction from its own national target rather than toward it.

The childhood target shows a slightly more encouraging, if still incomplete, picture: the 27% overweight/obesity rate in 2022–24 is not statistically different from the 25% recorded in 2017–18, meaning the rate has essentially plateaued rather than continuing to climb as it did between 1995 and 2017. Whether that represents genuine progress or simply a pause before further growth remains an open question that the AIHW says will require continued monitoring through the remainder of the decade, particularly as the impact of newer interventions like expanded GLP-1 medication access and community-based prevention programs becomes measurable in future national health surveys.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE